Julius Clinical

𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿: 𝗣𝗹𝗮𝘀𝗺𝗮 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗳𝗼𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗼𝗳 𝗡𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀. We invite you to join our webinar on "Plasma Biomarkers for Diagnosis and Monitoring of Neurodegenerative Disorders'', scheduled for October 15th. During this webinar, our speaker Charlotte Teunissen and host Lieza G. Exalto will explore the latest advancements and practical applications of plasma biomarkers in the field of neurodegenerative diseases. Topics to be covered: - Plasma biomarkers, including Amyloid, pTau, and NfL - Assessing treatment effects in neurodegenerative diseases - Innovations in diagnostic approaches Don't miss this opportunity to enhance your understanding of cutting-edge research and its clinical implications. Register now: https://lnkd.in/ecEv3a7B

As the 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝗙𝗿𝗼𝗻𝘁𝗼𝘁𝗲𝗺𝗽𝗼𝗿𝗮𝗹 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮 (𝗜𝗦𝗙𝗧𝗗) 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 officially begins, our team, concisting of Lieza G. Exalto and Maria Papakrasa, is already deep in discussions on critical topics like ALS FTD, prevention, lived experiences, and platform trials. If you're attending the conference and want to explore how we can support your clinical trial, feel free to reach out to either of them. https://lnkd.in/dihX_Caq

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐃𝐞𝐜𝐞𝐧𝐭𝐫𝐚𝐥𝐢𝐳𝐞𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬. Today, the FDA has issued a final guidance on Conducting Clinical Trials with Decentralized Elements. This new guidance outlines recommendations for incorporating decentralized elements into clinical trials, including telehealth visits, remote trials, and in-home assessments. These advancements are set to enhance convenience, expand access, and improve trial efficiencies, particularly for rare diseases and those affecting populations with limited mobility. As we embrace these changes, join us for an insightful round table discussion on "𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: 𝐀 𝐃𝐞𝐞𝐩 𝐃𝐢𝐯𝐞 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐃𝐞𝐜𝐞𝐧𝐭𝐫𝐚𝐥𝐢𝐳𝐞𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 𝐢𝐧 𝐄𝐩𝐢𝐥𝐞𝐩𝐬𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡." 🗓 Date: September 24, 2024 🕒 Time: 14:00 – 16:00 EDT This event will explore how decentralized clinical trials (DCTs) are transforming research in epilepsy. Hear from leading neurologists, project managers, and patients, and gain valuable insights from Praxis Precision Medicines, Inc., ECET - European Consortium for Epilepsy Trials, ERN EpiCARE - Rare and Complex Epilepsies, Epilepsy Foundation, and ESCI. 📍 Register here: https://lnkd.in/etyEX5Jm To read the guidance, visit: https://lnkd.in/eR_4SVmj

Next week we organize the exclusive round table event: "𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄: 𝗮 𝗱𝗲𝗲𝗽 𝗱𝗶𝘃𝗲 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗿𝗼𝗹𝗲 𝗼𝗳 𝗱𝗲𝗰𝗲𝗻𝘁𝗿𝗮𝗹𝗶𝘇𝗲𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻 𝗘𝗽𝗶𝗹𝗲𝗽𝘀𝘆 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵." September 24, 2024 | Time: 14.00 – 16.00 EDT Explore the future of epilepsy trials as we discuss the potential of decentralized clinical trials (DCTs) to transform research in this field. With expert insights from leading neurologists, project managers, and patients, and contributions from Praxis Precision Medicines, Inc., ECET - European Consortium for Epilepsy Trials, ERN EpiCARE - Rare and Complex Epilepsies, Epilepsy Foundation and ESCI, this is a must-attend event for those shaping the future of epilepsy research. 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝘀𝗽𝗼𝘁𝘀 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 – Reserve yours now: via Maria Papakrasa or visit: https://lnkd.in/etyEX5Jm

Our team is excited to be at the 𝗘𝗔𝗦𝗗 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 this week! Vivian de Jong, Elizabeth Liaño Callahan, Manuel Castro Cabezas and Weiwei X. are ready for an inspiring few days of learning, collaboration, and meaningful discussions around the latest in diabetes research. If you're attending and would like to connect, feel free to reach out to Elizabeth Liaño Callahan.

Join us for our exclusive round table event: "𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄: 𝗮 𝗱𝗲𝗲𝗽 𝗱𝗶𝘃𝗲 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗿𝗼𝗹𝗲 𝗼𝗳 𝗱𝗲𝗰𝗲𝗻𝘁𝗿𝗮𝗹𝗶𝘇𝗲𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻 𝗘𝗽𝗶𝗹𝗲𝗽𝘀𝘆 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵." Explore the future of epilepsy trials as we discuss the potential of decentralized clinical trials (DCTs) to transform research in this field. With expert insights from leading neurologists, project managers, and patients, and contributions from Praxis Precision Medicines, Inc., ECET - European Consortium for Epilepsy Trials, ERN EpiCARE - Rare and Complex Epilepsies, Epilepsy Foundation and ESCI, this is a must-attend event for those shaping the future of epilepsy research. 🗓️ Date: September 24, 2024 🕑 Time: 14.00 – 16.00 EDT 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝘀𝗽𝗼𝘁𝘀 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 – Reserve yours now: via Maria Papakrasa or visit: https://lnkd.in/etyEX5Jm Secure your place for this engaging and impactful discussion!

Join us for #RBQMLive2024 on September 24-25, the premier virtual event for Risk-Based Quality Management (RBQM). On September 25, don’t miss our colleague Lotte Smets, Director of Data Management, as she joins the panel"𝗥𝗕𝗤𝗠 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 – 𝗔𝗱𝗮𝗽𝘁𝗶𝗻𝗴 𝘁𝗼 𝗠𝗼𝗱𝗲𝗿𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻" from 8:30 – 9:30 am. Gain insights on evolving industry guidance, integrating quality by design, and ensuring inspection readiness with top experts in the field. For more information and to register, visit: https://rbqmlive.com/ https://lnkd.in/eeyzj6Uj

Next week, our colleagues Lieza G. Exalto and Maria Papakrasa will be attending the 𝟭𝟰𝘁𝗵 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗼𝗻 𝗙𝗿𝗼𝗻𝘁𝗼𝘁𝗲𝗺𝗽𝗼𝗿𝗮𝗹 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮𝘀 (𝗜𝗦𝗙𝗧𝗗𝟮𝟬𝟮𝟰) in Amsterdam (19-22 September). With recent advances in the field, including new insights into the molecular basis and therapeutic options, this event will gather top researchers, clinicians, and caregivers to share the latest findings and developments. It’s a fantastic opportunity to network, exchange knowledge, and explore new therapeutic perspectives. We look forward to connecting with everyone at ISFTD2024! Want to set up a meeting, please contact Maria Papakrasa directly.

Next week, our colleagues Ricard Quingles, Manuel Castro Cabezas, Vivian de Jong and Elizabeth Liaño Callahan will be attending the 𝗘𝗔𝗦𝗗 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟰. With EASD 2024 just around the corner, we’re gearing up for an incredible week of learning, collaboration, and innovation in diabetes research. We’re also excited for some great meetings and discussions! If you’d like to schedule a meeting with our team, feel free to reach out to Elizabeth Liaño Callahan. We’d love to connect! See you at EASD 2024!

We’re excited to announce, that Alina Saidi’s, a PhD student in the Department of Internal Medicine at Sint Franciscus Gasthuis, abstract titled "𝗟𝗶𝘃𝗲𝗿 𝗙𝗶𝗯𝗿𝗼𝘀𝗶𝘀 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝘀 𝗢𝗯𝗲𝘀𝗲 𝗦𝘂𝗯𝗷𝗲𝗰𝘁𝘀 𝗮𝘁 𝗛𝗶𝗴𝗵𝗲𝘀𝘁 𝗥𝗶𝘀𝗸 𝗳𝗼𝗿 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝗶𝘀𝗲𝗮𝘀𝗲" has been selected for an oral presentation at the upcoming 𝗔𝗻𝗻𝘂𝗮𝗹 𝗗𝘂𝘁𝗰𝗵 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 (𝗔𝗗𝗗𝗥𝗠) 𝟮𝟬𝟮𝟰. The abstract investigates the relationship between liver fibrosis, as measured by the Fibrosis-4 (FIB-4) index, and cardiovascular risk in patients with severe obesity. It reveals that individuals with a high FIB-4 score face increased cardiovascular risk, highlighting the importance of assessing liver fibrosis to identify those who are at the highest cardiovascular risk. Alina Saidi is honoured to share these findings at the ADDRM, which will take place from November 14 and 15 in Wageningen. More details about the meeting can be found here: https://www.addrm.online/